Eva Y-h Lee

Title: Eva Y-h Lee: Innovator in Genetic Research

Introduction

Eva Y-h Lee is a prominent inventor based in San Diego, California. She has made significant contributions to the field of genetic research, particularly in the study of cancer-related genes. With a total of six patents to her name, her work has had a profound impact on the understanding and treatment of various cancers.

Latest Patents

Among her latest patents is a method for producing retinoblastoma gene protein products. This innovative method allows for the substantial production of desired polypeptides by delivering genetic material into insect cells. The process involves utilizing cloned genes or gene fragments, which are introduced into host cells for high-level production of high-purity proteins in significant quantities. Another notable patent focuses on the retinoblastoma gene, which serves as a cancer suppressor and regulator. This invention encompasses the cloning, isolation, identification, and sequencing of the retinoblastoma gene. It also provides methods for diagnosing retinoblastoma, osteosarcoma, and fibrosarcoma, highlighting the gene's role in oncogenesis.

Career Highlights

Eva Y-h Lee is affiliated with the University of California, where she continues her research and innovation in genetic studies. Her work has not only advanced scientific knowledge but has also paved the way for potential therapeutic applications in cancer treatment.

Collaborations

Some of her notable coworkers include Wen-Hwa Lee and Huei-Jen Su Huang, who have collaborated with her on various research projects.

Conclusion

Eva Y-h Lee's contributions to genetic research and her innovative patents underscore her role as a leading inventor in the field. Her work continues to inspire advancements in cancer diagnosis and treatment.